In the BioHarmony Drug Report Database

"Preview" Icon

Frovatriptan

Frova (frovatriptan) is a small molecule pharmaceutical. Frovatriptan was first approved as Frova on 2001-11-08. It is used to treat migraine disorders in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D. In addition, it is known to target 5-hydroxytryptamine receptor 1A.

 

Trade Name

 

Frova
 

Common Name

 

frovatriptan
 

ChEMBL ID

 

CHEMBL1279
 

Indication

 

migraine disorders
 

Drug Class

 

Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

Image (chem structure or protein)

Frovatriptan structure rendering